Sunshine Biopharma, Inc. (SBFM)
2.71
-0.08
(-2.87%)
USD |
NASDAQ |
Nov 06, 16:00
2.76
+0.05
(+1.85%)
After-Hours: 05:51
Sunshine Biopharma Market Cap : 0.3236M for Nov. 6, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 06, 2026 | 0.3236M |
| November 05, 2026 | 0.3331M |
| November 04, 2026 | 0.3164M |
| November 03, 2026 | 0.3272M |
| November 02, 2026 | 0.3284M |
| October 30, 2026 | 0.3498M |
| October 29, 2026 | 0.3976M |
| October 28, 2026 | 0.3713M |
| October 27, 2026 | 0.3534M |
| October 26, 2026 | 0.3164M |
| October 23, 2026 | 0.3582M |
| October 22, 2026 | 0.3988M |
| October 21, 2026 | 0.5144M |
| October 20, 2026 | 10.51M |
| October 19, 2026 | 11.55M |
| October 16, 2026 | 10.60M |
| October 15, 2026 | 10.99M |
| October 14, 2026 | 11.61M |
| October 13, 2026 | 11.29M |
| October 12, 2026 | 14.43M |
| October 09, 2026 | 16.14M |
| October 08, 2026 | 20.54M |
| October 07, 2026 | 33.44M |
| October 06, 2026 | 19.01M |
| October 05, 2026 | 20.07M |
| Date | Value |
|---|---|
| October 02, 2026 | 31.84M |
| October 01, 2026 | 32.85M |
| September 30, 2026 | 36.93M |
| September 29, 2026 | 37.61M |
| September 28, 2026 | 39.07M |
| September 25, 2026 | 40.25M |
| September 24, 2026 | 38.22M |
| September 23, 2026 | 41.84M |
| September 22, 2026 | 43.29M |
| September 21, 2026 | 43.43M |
| September 18, 2026 | 42.98M |
| September 17, 2026 | 40.18M |
| September 16, 2026 | 49.20M |
| September 15, 2026 | 49.20M |
| September 14, 2026 | 51.11M |
| September 11, 2026 | 50.64M |
| September 10, 2026 | 51.59M |
| September 09, 2026 | 53.50M |
| September 08, 2026 | 54.94M |
| September 04, 2026 | 54.46M |
| September 03, 2026 | 53.02M |
| September 02, 2026 | 55.89M |
| September 01, 2026 | 53.98M |
| August 31, 2026 | 53.50M |
| August 28, 2026 | 54.94M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.654B |
| Alnylam Pharmaceuticals, Inc. | 20.88B |
| Anika Therapeutics, Inc. | 194.72M |
| Savara, Inc. | 992.08M |
| Vericel Corp. | 2.795B |
Market Cap Related Metrics
| PS Ratio | 0.0027 |
| Price to Book Value | 0.0118 |
| Price | 2.71 |
| Earnings Yield | -7.55K% |